Author

D. Khamrai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Sain· 2 shared D. Naskar· 2 shared B. Simpi· 1 shared M. Srinivas· 1 shared M. Varshney· 1 shared P. Singh· 1 shared S. Barman· 1 shared T. Kandasamy· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Sain

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Olive phenolic compounds, potent tankyrase 1 inhibitor exhibit anti colon cancer effects by blocking Wnt/β-catenin pathway

A. Sain, S. Barman, D. Khamrai, M. Srinivas, P. Singh, B. Simpi, M. Varshney, D. Naskar

This study identifies olive polyphenols as tankyrase 1 inhibitors that suppress the Wnt/β-catenin pathway, reducing colon cancer cell viability and target gene expression.

bioRxiv · May 8, 2024 · PreprintCancer Biology

Apigenin exerts anti-cancer effects in colon cancer possibly by regulating Heat shock protein 90 alpha family class A member 1 (HSP90AA1)

D. Naskar, A. Sain, D. Khamrai, T. Kandasamy

This study identifies HSP90AA1 as a key target of apigenin in colon cancer, showing its anti-cancer effects through reduced HSP90AA1 expression and improved patient survival.

bioRxiv · Mar 24, 2023 · PreprintCancer Biology